Ying Li (Yan Luo)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Yan Luo, Juan Jiang, Junxiong Cheng, Chen Xuan, Yu Xiong, Weijian Xiong, Wenfu Cao, Ying Li
Inhibitory Effects of Rhein on Renal Interstitial Fibrosis via the SHH-Gli1 Signal Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Na Song, Haitao Tu, Ying Li, Weijian Xiong, Ling Zhang, Hong Liu, Weisen Ding, Mei Long, Dewei Ren, Jin Zhong
Inhibitory Potential of Shen-Shuai-Ling Formulation on Renal Interstitial Fibrosis via Upregulation of PLZF. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Ying Li, Haitao Tu, Ying Li, Weijian Xiong, Hong Liu, Yanying Xiong, Qin Zhang, Huihui Li, Xuan Gao
Shen-Shuai-Ling Formulation Attenuates Renal Interstitial Fibrosis in Chronic Kidney Disease by Regulating SHH-Gli1 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)